APP and Alzheimer disease: With regards to the amyloid-β (Aβ) hypothesis for AD development [8,9], APOE4 can regulate amyloid precursor protein (APP) processing, Aβ production, and potentially Aβ aggregation via several mechanisms including the LRP (lipoprotein receptor-related protein) pathway [1,10].